Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

The Siah1 and Siah2 genes are active in mouse skin development and hair growth, especially right after birth.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Clascoterone may be an effective topical treatment for hair loss.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

ERG increases SOX9, promoting prostate cancer growth and invasion.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

New genes linked to male pattern baldness were found on chromosome 20p11.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.